Interleukin-1-alpha - Dainippon Sumitomo Pharma/Roche

Drug Profile

Interleukin-1-alpha - Dainippon Sumitomo Pharma/Roche

Alternative Names: Interleukin-1-alpha - Dainippon Sumitomo Pharma; rIL-1 alpha

Latest Information Update: 29 Jan 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dainippon Sumitomo Pharma
  • Developer Dainippon Sumitomo Pharma; National Cancer Institute (USA)
  • Class Interleukins
  • Mechanism of Action Granulocyte colony stimulating factor stimulants; Granulocyte macrophage colony stimulating factor agonists; Interleukin 1-alpha stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Malignant melanoma; Non-small cell lung cancer

Most Recent Events

  • 01 Oct 2005 Sumitomo Pharmaceuticals has merged with Dainippon Pharmaceutical to form Dainippon Sumitomo Pharma
  • 05 Jun 2001 Discontinued-Clinical for Malignant melanoma in Japan (Intralesional)
  • 05 Jun 2001 Discontinued-Clinical for Non-small cell lung cancer in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top